Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1991 Apr 15;88(8):3060–3064. doi: 10.1073/pnas.88.8.3060

An idiotypic network model of AIDS immunopathogenesis.

G W Hoffmann 1, T A Kion 1, M D Grant 1
PMCID: PMC51384  PMID: 1901653

Abstract

Considerations from a network theory of the immune system suggest that human immunodeficiency virus and allogeneic stimuli may act synergistically to cause AIDS. The immune responses to these stimuli include two components that are directed against each other. In some AIDS risk groups other antigens that mimic major histocompatibility complex antigens may substitute for allogeneic stimuli. Implications for the prevention of AIDS are discussed.

Full text

PDF
3060

Images in this article

3061Image
on p.3061
3061Image
on p.3061

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. C., van Schooten W. C., Barry M. E., Janson A. A., Buchanan T. M., de Vries R. R. A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide. Science. 1988 Oct 14;242(4876):259–261. doi: 10.1126/science.2459778. [DOI] [PubMed] [Google Scholar]
  2. Andrieu J. M., Even P., Venet A. AIDS and related syndromes as a viral-induced autoimmune disease of the immune system: an anti-MHC II disorder. Therapeutic implications. AIDS Res. 1986 Summer;2(3):163–174. doi: 10.1089/aid.1.1986.2.163. [DOI] [PubMed] [Google Scholar]
  3. Binz H., Wigzell H. Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. I. Demonstration of similar or identical idiotypes on IgG molecules and T-cell receptors with specificity for the same alloantigens. J Exp Med. 1975 Jul 1;142(1):197–211. doi: 10.1084/jem.142.1.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Calabrese L. H. Autoimmune manifestations of human immunodeficiency virus (HIV) infection. Clin Lab Med. 1988 Jun;8(2):269–279. [PubMed] [Google Scholar]
  5. Choi E. K., Gatenby P. A., McGill N. W., Bateman J. F., Cole W. G., York J. R. Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides, autoimmune connective tissue diseases, and chronic inflammatory syndromes. Ann Rheum Dis. 1988 Apr;47(4):313–322. doi: 10.1136/ard.47.4.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clayton L. K., Sieh M., Pious D. A., Reinherz E. L. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature. 1989 Jun 15;339(6225):548–551. doi: 10.1038/339548a0. [DOI] [PubMed] [Google Scholar]
  7. Diamond D. C., Sleckman B. P., Gregory T., Lasky L. A., Greenstein J. L., Burakoff S. J. Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. J Immunol. 1988 Dec 1;141(11):3715–3717. [PubMed] [Google Scholar]
  8. Duesberg P. H. AIDS: non-infectious deficiencies acquired by drug consumption and other risk factors. Res Immunol. 1990 Jan;141(1):5–11. doi: 10.1016/0923-2494(90)90097-i. [DOI] [PubMed] [Google Scholar]
  9. Gay D., Maddon P., Sekaly R., Talle M. A., Godfrey M., Long E., Goldstein G., Chess L., Axel R., Kappler J. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature. 1987 Aug 13;328(6131):626–629. doi: 10.1038/328626a0. [DOI] [PubMed] [Google Scholar]
  10. Giorgi J. V., Fahey J. L., Smith D. C., Hultin L. E., Cheng H. L., Mitsuyasu R. T., Detels R. Early effects of HIV on CD4 lymphocytes in vivo. J Immunol. 1987 Jun 1;138(11):3725–3730. [PubMed] [Google Scholar]
  11. Golding H., Robey F. A., Gates F. T., 3rd, Linder W., Beining P. R., Hoffman T., Golding B. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J Exp Med. 1988 Mar 1;167(3):914–923. doi: 10.1084/jem.167.3.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Golding H., Shearer G. M., Hillman K., Lucas P., Manischewitz J., Zajac R. A., Clerici M., Gress R. E., Boswell R. N., Golding B. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest. 1989 Apr;83(4):1430–1435. doi: 10.1172/JCI114034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grant M. D., Weaver M. S., Tsoukas C., Hoffmann G. W. Distribution of antibodies against denatured collagen in AIDS risk groups and homosexual AIDS patients suggests a link between autoimmunity and the immunopathogenesis of AIDS. J Immunol. 1990 Feb 15;144(4):1241–1250. [PubMed] [Google Scholar]
  14. Grossman Z. Recognition of self, balance of growth and competition: horizontal networks regulate immune responsiveness. Eur J Immunol. 1982 Sep;12(9):747–756. doi: 10.1002/eji.1830120909. [DOI] [PubMed] [Google Scholar]
  15. Gunther N., Hoffmann G. W. Qualitative dynamics of a network model of regulation of the immune system: a rationale for the IgM to IgG switch. J Theor Biol. 1982 Feb 21;94(4):815–822. doi: 10.1016/0022-5193(82)90080-7. [DOI] [PubMed] [Google Scholar]
  16. Habeshaw J. A., Dalgleish A. G. The relevance of HIV env/CD4 interactions to the pathogenesis of acquired immune deficiency syndrome. J Acquir Immune Defic Syndr. 1989;2(5):457–468. [PubMed] [Google Scholar]
  17. Hoffenbach A., Langlade-Demoyen P., Dadaglio G., Vilmer E., Michel F., Mayaud C., Autran B., Plata F. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol. 1989 Jan 15;142(2):452–462. [PubMed] [Google Scholar]
  18. Hoffmann G. W. A theory of regulation and self-nonself discrimination in an immune network. Eur J Immunol. 1975 Sep;5(9):638–647. doi: 10.1002/eji.1830050912. [DOI] [PubMed] [Google Scholar]
  19. Hoffmann G. W., Cooper-Willis A., Chow M. A new symmetry: A anti-B is anti-(B anti-A), and reverse enhancement. J Immunol. 1986 Jul 1;137(1):61–68. [PubMed] [Google Scholar]
  20. Hoffmann G. W. On network theory and H-2 restriction. Contemp Top Immunobiol. 1980;11:185–226. doi: 10.1007/978-1-4684-3701-0_6. [DOI] [PubMed] [Google Scholar]
  21. Jerne N. K. Towards a network theory of the immune system. Ann Immunol (Paris) 1974 Jan;125C(1-2):373–389. [PubMed] [Google Scholar]
  22. Karpatkin S., Nardi M., Lennette E. T., Byrne B., Poiesz B. Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9763–9767. doi: 10.1073/pnas.85.24.9763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kaye B. R. Rheumatologic manifestations of infection with human immunodeficiency virus (HIV). Ann Intern Med. 1989 Jul 15;111(2):158–167. doi: 10.7326/0003-4819-111-2-158. [DOI] [PubMed] [Google Scholar]
  24. Lamarre D., Ashkenazi A., Fleury S., Smith D. H., Sekaly R. P., Capon D. J. The MHC-binding and gp120-binding functions of CD4 are separable. Science. 1989 Aug 18;245(4919):743–746. doi: 10.1126/science.2549633. [DOI] [PubMed] [Google Scholar]
  25. Lanzavecchia A. Harming and protecting responses to HIV. Res Immunol. 1989 Jan;140(1):99–124. doi: 10.1016/0923-2494(89)90012-6. [DOI] [PubMed] [Google Scholar]
  26. Lasky L. A., Nakamura G., Smith D. H., Fennie C., Shimasaki C., Patzer E., Berman P., Gregory T., Capon D. J. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell. 1987 Sep 11;50(6):975–985. doi: 10.1016/0092-8674(87)90524-1. [DOI] [PubMed] [Google Scholar]
  27. Martínez-A C., Marcos M. A., de la Hera A., Marquez C., Alonso J. M., Toribio M. L., Coutinho A. Immunological consequences of HIV infection: advantage of being low responder casts doubts on vaccine development. Lancet. 1988 Feb 27;1(8583):454–457. doi: 10.1016/s0140-6736(88)91244-5. [DOI] [PubMed] [Google Scholar]
  28. Peña Rossi C., Pereira P., Portnoï D., Coutinho A. Major histocompatibility complex-linked and T cell-dependent selection of antibody repertoires. Quantitation of I-E-related specificities in normal mice. Eur J Immunol. 1989 Oct;19(10):1941–1946. doi: 10.1002/eji.1830191027. [DOI] [PubMed] [Google Scholar]
  29. Ramseier H., Lindenmann J. Aliotypic antibodies. Transplant Rev. 1972;10:57–96. doi: 10.1111/j.1600-065x.1972.tb01539.x. [DOI] [PubMed] [Google Scholar]
  30. Rosenstein Y., Burakoff S. J., Herrmann S. H. HIV-gp120 can block CD4-class II MHC-mediated adhesion. J Immunol. 1990 Jan 15;144(2):526–531. [PubMed] [Google Scholar]
  31. Sattentau Q. J., Dalgleish A. G., Weiss R. A., Beverley P. C. Epitopes of the CD4 antigen and HIV infection. Science. 1986 Nov 28;234(4780):1120–1123. doi: 10.1126/science.2430333. [DOI] [PubMed] [Google Scholar]
  32. Schnittman S. M., Psallidopoulos M. C., Lane H. C., Thompson L., Baseler M., Massari F., Fox C. H., Salzman N. P., Fauci A. S. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science. 1989 Jul 21;245(4915):305–308. doi: 10.1126/science.2665081. [DOI] [PubMed] [Google Scholar]
  33. Schwartz S. A. Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders. J Clin Immunol. 1990 Mar;10(2):81–89. doi: 10.1007/BF00918189. [DOI] [PubMed] [Google Scholar]
  34. Shearer G. M. AIDS: an autoimmune pathologic model for the destruction of a subset of helper T lymphocytes. Mt Sinai J Med. 1986 Dec;53(8):609–615. [PubMed] [Google Scholar]
  35. Shearer G. M. Allogeneic leukocytes as a possible factor in induction of aids in homosexual men. N Engl J Med. 1983 Jan 27;308(4):223–224. doi: 10.1056/NEJM198301273080415. [DOI] [PubMed] [Google Scholar]
  36. Shoenfeld Y., Isenberg D. A. Mycobacteria and autoimmunity. Immunol Today. 1988 Jun;9(6):178–182. doi: 10.1016/0167-5699(88)91294-7. [DOI] [PubMed] [Google Scholar]
  37. Siliciano R. F., Lawton T., Knall C., Karr R. W., Berman P., Gregory T., Reinherz E. L. Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell. 1988 Aug 12;54(4):561–575. doi: 10.1016/0092-8674(88)90078-5. [DOI] [PubMed] [Google Scholar]
  38. Tarkowski A., Holmdahl R., Rubin K., Klareskog L., Nilsson L. A., Gunnarsson K. Patterns of autoreactivity to collagen type II in autoimmune MRL/l mice. Clin Exp Immunol. 1986 Feb;63(2):441–449. [PMC free article] [PubMed] [Google Scholar]
  39. Vega M. A., Guigó R., Smith T. F. Autoimmune response in AIDS. Nature. 1990 May 3;345(6270):26–26. doi: 10.1038/345026a0. [DOI] [PubMed] [Google Scholar]
  40. Weinhold K. J., Lyerly H. K., Stanley S. D., Austin A. A., Matthews T. J., Bolognesi D. P. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J Immunol. 1989 May 1;142(9):3091–3097. [PubMed] [Google Scholar]
  41. Westall F. C., Root-Bernstein R. S. An explanation of prevention and suppression of experimental allergic encephalomyelitis. Mol Immunol. 1983 Feb;20(2):169–177. doi: 10.1016/0161-5890(83)90128-1. [DOI] [PubMed] [Google Scholar]
  42. Westall F. C., Root-Bernstein R. Cause and prevention of postinfectious and postvaccinal neuropathies in light of a new theory of autoimmunity. Lancet. 1986 Aug 2;2(8501):251–252. doi: 10.1016/s0140-6736(86)92073-8. [DOI] [PubMed] [Google Scholar]
  43. Young J. A. HIV and HLA similarity. Nature. 1988 May 19;333(6170):215–215. doi: 10.1038/333215c0. [DOI] [PubMed] [Google Scholar]
  44. Ziegler J. L., Stites D. P. Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin Immunol Immunopathol. 1986 Dec;41(3):305–313. doi: 10.1016/0090-1229(86)90001-2. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES